Finance

Cytori Therapeutics receives $1.5 million payment for option granted to Olympus

Published in Health and Medicine Week, June 1st, 2006

Cytori Therapeutics, Inc. (CYTX; XMPA) announced it has received a $1.5 million payment for the option it granted to Olympus Corporation for the exclusive right to negotiate an adipose-derived stem and regenerative cell commercialization collaboration.

The collaboration would include distribution rights to the Celution System and related one-time use cartridges for a specific therapeutic area outside of cardiovascular disease.

As part of the agreement signed in February 2006, Olympus will conduct market research and pilot clinical studies in collaboration with Cytori over a 12- to 18-month period for the therapeutic area. The studies will be...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week

Source: Health and Medicine Week (2006-06-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry